Phibro Animal Health
PAHC
208 hedge funds and large institutions have $660M invested in Phibro Animal Health in 2026 Q2 according to their latest regulatory filings, with 34 funds opening new positions, 81 increasing their positions, 76 reducing their positions, and 80 closing their positions.
1.01% more ownership
Funds ownership: 98.72% → 99.73% (+1%)
7% more repeat investments, than reductions
Existing positions increased: 81 | Existing positions reduced: 76
4% more capital inflows, than outflows
Capital inflows: $166M | Capital outflows: $159M
19% less funds holding
Funds holding: 257 → 208 (-49)
58% less first-time investments, than exits
New positions opened: 34 | Existing positions closed: 80
76% less call options, than puts
Call options by funds: $477K | Put options by funds: $1.96M
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$41.7M |
| 2 |
Millennium Management
New York
|
+$37.2M |
| 3 |
CM
CastleKnight Management
New York
|
+$16.3M |
| 4 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
+$10.8M |
| 5 |
HAI
Hennessy Advisors Inc
Novato,
California
|
+$9.35M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Acadian Asset Management
Boston,
Massachusetts
|
-$16.5M |
| 2 |
CFM
Capricorn Fund Managers
London,
United Kingdom
|
-$14.8M |
| 3 |
CM
Castleark Management
Chicago,
Illinois
|
-$7.9M |
| 4 |
Nuveen
Charlotte,
North Carolina
|
-$5.98M |
| 5 |
Barclays
London,
United Kingdom
|
-$5.47M |
PAHC Hedge Fund Activity: Q2 2026 in Review
208 of the 8,352 institutional investors tracked by Wall St. Rank reported a position in Phibro Animal Health (PAHC) for Q2 2026, worth a combined $660M — down 41% from $1.12B a quarter earlier.
Sellers outnumbered buyers: 80 funds closed out of PAHC and 34 opened new positions — a net loss of 46 holders — while 76 trimmed existing stakes and 81 added.
The largest buyer was Fidelity Investments, adding an estimated $41.7M. The largest seller was Acadian Asset Management, cutting an estimated $16.5M.
- 208 institutional investors held Phibro Animal Health (PAHC) as of Q2 2026, down from 257 in Q1 2026.
- Funds reported $660M of Phibro Animal Health stock for Q2 2026, down 41% quarter-over-quarter.
- 34 funds opened new Phibro Animal Health positions in Q2 2026 and 80 closed out, a net change of -46 holders.
- The largest Phibro Animal Health buyer in Q2 2026 was Fidelity Investments, an estimated $41.7M added.
- The largest Phibro Animal Health seller in Q2 2026 was Acadian Asset Management, an estimated $16.5M sold.
Based on aggregated 13F filings for Q2 2026.